REQUEST A DEMO
Total
USD $0.00
Search more companies

EyeGene, Inc. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: EyeGene, Inc. Profile Updated: January 28, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

EyeGene, Inc. is a company in South Korea, with a head office in Seoul. The enterprise currently operates in the Pharmaceutical and Medicine Manufacturing sector. It was established on June 23, 2000. EyeGene, Inc. currently employs 48 (2024) people. There was a net sales revenue increase of 36.59% reported in EyeGene, Inc.’s latest financial highlights for Q3C2025. There was a total negative growth of 16.48% in EyeGene, Inc.’s total assets over the same period. The net profit margin of EyeGene, Inc. increased by 246.16% in 2025.

Headquarters
330 Seongam-Ro, Mapo-Gu
Seoul; Seoul;

Contact Details: Purchase the EyeGene, Inc. report to view the information.

Website: http://www.eyegene.co.kr

Basic Information
Total Employees:
Purchase the EyeGene, Inc. report to view the information.
Outstanding Shares:
Purchase the EyeGene, Inc. report to view the information.
Registered Capital:
Purchase the EyeGene, Inc. report to view the information.
Financial Auditors:
Purchase the EyeGene, Inc. report to view the information.
Incorporation Date:
June 23, 2000
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Technology Officer
Purchase this report to view the information.
Chief Technology Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
8.8%
Purchase this report to view the information.
5.2%
Purchase this report to view the information.
0.3%
Subsidiaries
(주)레나임
Eyegene Australia Pty Ltd
Company Performance
Financial values in the chart are available after EyeGene, Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
36.59%
Total operating revenue
26.91%
Operating Profit/Loss (EBIT)
33.58%
EBITDA
44.28%
Net Profit/Loss for the Period
31.02%
Total Assets
-16.48%
Total Equity
-17.5%
Operating Profit Margin (ROS)
276.1%
Net Profit Margin
246.16%
Return on Equity (ROE)
3.12%
Debt/Equity
-1.89%
Quick Ratio
-2.33%
Cash Ratio
0.25%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?